ProUroCare Medical Inc. (PUMD)
ProUroCare Medical Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Eden Prairie, MN, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,860. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 0.31 implies it has historically moved less than the broad market.
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
ProUroCare Medical Inc. is most often compared with the following Healthcare names: